Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer

Clinical trial NCT00100750 · COMPLETED

Trial details

NCT number: NCT00100750
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Breast Carcinoma Stage IV Breast Cancer

Start date: 2005-09-01
Primary completion: 2007-10-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.